Putting a spotlight on critical unmet healthcare needs

2019-11-19


Putting a spotlight on critical unmet healthcare needs


D&D Pharmatech funds the development of innovative therapeutic and diagnostic solutions to address critical unmet healthcare needs. D&D subsidiary Theraly Fibrosis is developin a novel treatment for chronic pancreatitis and other fibrosis, recently granted an orphan drug designation from the US FDA.

Link: https://biopharmadealmakers.nature.com/users/331694-d-d-pharmatech/documents/56407-d-d-pharmatech-november-2019